Last updated on November 2019
IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation Therapy
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Non-Small Cell Lung Cancer
-
Age: - 100 Years
-
Gender: Male or Female
Inclusion Criteria:
-Patients with locally advanced unresectable non-small cell lung cancer who are treated with IMFINZI for the first time as maintenance therapy after definitive chemoradiation therapy
Exclusion Criteria:
-No past history of hypersensitivity to the components of IMFINZI